Doripenem

In the US, Doripenem (doripenem systemic) is a member of the drug class carbapenems and is used to treat Intraabdominal Infection, Kidney Infections and Urinary Tract Infection.

US matches:

• Doripenem


• Doripenem Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DH04

CAS registry number (Chemical Abstracts Service)

0148016-81-3

Chemical Formula

C15-H24-N4-O6-S2

Molecular Weight

420

Therapeutic Category

Antibacterial: Beta-lactam

Chemical Name

(+)-(4R,5S,6S)-6-[(1R)-1-Hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carobxylic acid (WHO)

Foreign Names

• Doripenemum (Latin)
• Doripenem (German)
• Doripénem (French)
• Doripenem (Spanish)

Generic Names

• Doripenem (OS: USAN)
• S-4661 (IS: JohnsonJohns)
• Doripenem monohydrate (IS)

Brand Names

• Doribax
  Janssen, Luxembourg; Janssen, Australia; Janssen, Germany; Janssen, Spain; Janssen, Finland; Janssen, Greece; Janssen-Cilag, Austria; Janssen-Cilag, Switzerland; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Sweden; Johnson & Johnson, United States



• Finibax
  Shionogi Seiyaku, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.